Key result
Elevated cerebrospinal fluid epinephrine levels independently predicted early mortality in patients with subarachnoid hemorrhage.
Why the study?
Do early cerebrospinal fluid catecholamine levels predict mortality or disability in patients with severe subarachnoid hemorrhage?
Observational (n=102)
Do early cerebrospinal fluid catecholamine levels predict mortality or disability in patients with severe subarachnoid hemorrhage?
Early cerebrospinal fluid epinephrine levels independently predict short-term mortality and disability in patients with severe subarachnoid hemorrhage.
Answers are grounded in this paper and cite their sources.
May inform early prognostication in subarachnoid hemorrhage; leaves open whether CSF epinephrine improves risk models.
OBJECTIVE: Subarachnoid hemorrhage (SAH) is associated with marked sympathetic activation at the time of ictus. The purpose of this study is to determine whether early central catecholamine levels measured from cerebrospinal fluid (CSF) relate to outcome in patients with SAH. METHODS: Observational study of consecutive SAH grade 3-5 patients who underwent ventriculostomy placement, but did not undergo open craniotomy for aneurysm obliteration. CSF samples were obtained during the first 48 h following symptom onset and assayed for catecholamine levels. Statistical analyses were performed to determine whether the levels predicted mortality by day 15 or mortality/disability by day 30. RESULTS: For the 102 patients included, mean age was 58, and 73% were female - 21% experienced day-15 mortality, and 32% experienced mortality/disability by day 30. Early mortality was related to Hunt-Hess (H/H) grade (p < 0.001), neurogenic cardiomyopathy (NC) (p = 0.003), cerebral infarction (p = 0.001), elevated intracranial pressure (ICP) (p = 0.029), epinephrine (EPI) level (p = 0.002) and norepinephrine/3,4-dihydroxyphenylglycol (NE/DHPG) ratio (p = 0.003). Mortality/disability was related to H/H grade (p < 0.001), NC (p = 0.018), infarction (p < 0.001), elevated ICP (p = 0.002), EPI (p = 0.004) and NE/DHPG (p = 0.014). Logistic regression identified age [OR 1.09 (95% CI 1.01-1.17)], H/H grade [9.52 (1.19-77)], infarction [10.87 (1.22-100)], ICP elevation [32.26 (2-500)], EPI [1.06 (1.01-1.10)], and (inversely) DHPG [0.99 (0.99-1.00)] as independent predictors of early mortality. For mortality/disability, H/H grade [OR 21.74 (95% CI 5.62-83)], ICP elevation [18.52 (1.93-166)], and EPI [1.05 (1.02-1.09)] emerged as independent predictors. Proportional-hazards analysis revealed age [HR 1.041 (95% CI 1.003-1.08)], H/H grade [6.9 (1.54-31.25)], NC [4.31 (1.5-12.35)], and EPI [1.032 (1.009-1.054)] independently predicted early mortality. CONCLUSIONS: CSF catecholamine levels are elevated in SAH patients who experience early mortality or disability. EPI may potentially serve as useful index of outcome in this population of patients with SAH.
No takes yet. Share an insight, caveat, or question.
Moussouttas et al. (2012) conducted an observational in Subarachnoid hemorrhage (SAH) (n=102). Cerebrospinal fluid epinephrine (EPI) levels was evaluated on Early mortality (by day 15) (HR 1.032, 95% CI 1.009-1.054, p=0.002). Elevated cerebrospinal fluid epinephrine levels independently predicted early mortality in patients with subarachnoid hemorrhage.
Synapse has enriched 10 related papers. Consider them for comparative context: